Marked difference in liver fat measured by histology vs. magnetic resonance-proton density fat fraction: A meta analysis

被引:22
作者
Qadri, Sami [1 ,2 ,3 ,17 ]
Vartiainen, Emilia [4 ]
Lahelma, Mari [1 ,2 ,3 ]
Porthan, Kimmo [1 ,3 ]
Tang, An [5 ]
Idilman, Ilkay S. [6 ]
Runge, Jurgen H. [2 ,7 ,8 ]
Juuti, Anne [9 ]
Penttila, Anne K. [9 ]
Dabek, Juhani [1 ,2 ,3 ]
Lehtimaki, Tiina E. [10 ]
Seppaenen, Wenla [10 ]
Arola, Johanna [2 ,11 ]
Arkkila, Perttu [12 ,13 ]
Stoker, Jaap [2 ,7 ,8 ]
Karcaaltincaba, Musturay
Pavlides, Michael [14 ]
Loomba, Rohit [15 ]
Sirlin, Claude B. [16 ]
Tukiainen, Taru
Yki-Jarvinen, Hannele [1 ,2 ,3 ,17 ]
机构
[1] Univ Helsinki, Dept Med, Helsinki, Finland
[2] Helsinki Univ Hosp, Helsinki, Finland
[3] Minerva Fdn, Inst Med Res, Helsinki, Finland
[4] Univ Helsinki, Inst Mol Med Finland FIMM, Helsinki, Finland
[5] Ctr hosp Univ Montreal CHUM, Dept Radiol, Montreal, PQ, Canada
[6] Hacettepe Univ, Sch Med, Dept Radiol, Liver Imaging Team, Ankara, Turkiye
[7] Amsterdam UMC Locat Univ Amsterdam, Dept Radiol & Nucl Med, Amsterdam, Netherlands
[8] Amsterdam Gastroenterol Endocrinol & Metab, Amsterdam, Netherlands
[9] Helsinki Univ Hosp, Abdominal Ctr, Dept Gastrointestinal Surg, Helsinki, Finland
[10] Helsinki Univ Hosp, HUS Med Imaging Ctr, Helsinki, Finland
[11] Univ Helsinki, Dept Pathol, Helsinki, Finland
[12] Helsinki Univ Hosp, Abdominal Ctr, Dept Gastroenterol, Helsinki, Finland
[13] Univ Helsinki, Helsinki, Finland
[14] Univ Oxford, Radcliffe Dept Med, Oxford, England
[15] Univ Calif San Diego, NAFLD Res Ctr, Dept Med, Div Gastroenterol & Hepatol, La Jolla, CA 92093 USA
[16] Univ Calif San Diego, Dept Radiol, Liver Imaging Grp, La Jolla, CA 92093 USA
[17] Biomedicum Helsinki, 1,Room A418a,Haartmaninkatu 8, Helsinki 00290, Finland
基金
芬兰科学院;
关键词
Fatty liver; Metabolic dysfunction-associated steatotic liver disease; Magnetic resonance imaging; Magnetic resonance spectroscopy; Biopsy; Histology; Hepatocytes; Pathologists; Triglycerides; Transcriptome; Systematic review; Meta-analysis; HEPATIC STEATOSIS; MR SPECTROSCOPY; FOLLOW-UP; DISEASE; QUANTIFICATION; ACCURACY; VARIABILITY; FIBROSIS; BIOPSIES; GRADES;
D O I
10.1016/j.jhepr.2023.100928
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Background & Aims: Pathologists quantify liver steatosis as the fraction of lipid droplet-containing hepatocytes out of all hepatocytes, whereas the magnetic resonance-determined proton density fat fraction (PDFF) reflects the tissue triacylglycerol concentration. We investigated the linearity, agreement, and correspondence thresholds between histological steatosis and PDFF across the full clinical spectrum of liver fat content associated with non-alcoholic fatty liver disease.Methods: Using individual patient-level measurements, we conducted a systematic review and meta-analysis of studies comparing histological steatosis with PDFF determined by magnetic resonance spectroscopy or imaging in adults with suspected non-alcoholic fatty liver disease. Linearity was assessed by meta-analysis of correlation coefficients and by linear mixed modelling of pooled data, agreement by Bland-Altman analysis, and thresholds by receiver operating characteristic analysis. To explain observed differences between the methods, we used RNA-seq to determine the fraction of hepatocytes in human liver biopsies.Results: Eligible studies numbered 9 (N = 597). The relationship between PDFF and histology was predominantly linear (r = 0.85 [95% CI, 0.80-0.89]), and their values approximately coincided at 5% steatosis. Above 5% and towards higher levels of steatosis, absolute values of the methods diverged markedly, with histology exceeding PDFF by up to 3.4-fold. On average, 100% histological steatosis corresponded to a PDFF of 33.0% (29.5-36.7%). Targeting at a specificity of 90%, optimal PDFF thresholds to predict histological steatosis grades were >= 5.75% for >= S1, >= 15.50% for >= S2, and >= 21.35% for S3. Hepatocytes comprised 58 +/- 5% of liver cells, which may partly explain the lower values of PDFF vs. histology.Conclusions: Histological steatosis and PDFF have non-perfect linearity and fundamentally different scales of measurement. Liver fat values obtained using these methods may be rendered comparable by conversion equations or threshold values.Impact and implications: Magnetic resonance-proton density fat fraction (PDFF) is increasingly being used to measure liver fat in place of the invasive liver biopsy. Understanding the relationship between PDFF and histological steatosis fraction is important for preventing misjudgement of clinical status or treatment effects in patient care. Our analysis revealed that histological steatosis fraction is often significantly higher than PDFF, and their association varies across the spectrum of fatty liver severity. These findings are particularly important for physicians and clinical researchers, who may use these data to interpret PDFF measurements in the context of histologically evaluated liver fat content.(c) 2023 The Author(s). Published by Elsevier B.V. on behalf of European Association for the Study of the Liver (EASL). This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).
引用
收藏
页数:13
相关论文
共 50 条
[1]   Magnetic Resonance Imaging Proton Density Fat Fraction Associates With Progression of Fibrosis in Patients With Nonalcoholic Fatty Liver Disease [J].
Ajmera, Veeral ;
Park, Charlie C. ;
Caussy, Cyrielle ;
Singh, Seema ;
Hernandez, Carolyn ;
Bettencourt, Ricki ;
Hooker, Jonathan ;
Sy, Ethan ;
Behling, Cynthia ;
Xu, Ronghui ;
Middleton, Michael S. ;
Valasek, Mark A. ;
Faulkner, Claire ;
Rizo, Emily ;
Richards, Lisa ;
Sirlin, Claude B. ;
Loomba, Rohit .
GASTROENTEROLOGY, 2018, 155 (02) :307-+
[2]   How to perform a meta-analysis with R: a practical tutorial [J].
Balduzzi, Sara ;
Ruecker, Gerta ;
Schwarzer, Guido .
EVIDENCE-BASED MENTAL HEALTH, 2019, 22 (04) :153-160
[3]  
Bates D, 2015, J STAT SOFTW, V67, P1, DOI [10.1007/s13201-024-02166-7, 10.3390/agronomy15020428]
[4]   EASL Clinical Practice Guidelines on non-invasive tests for evaluation of liver disease severity and prognosis-2021 update [J].
Berzigotti, Annalisa ;
Tsochatzis, Emmanouil ;
Boursier, Jerome ;
Castera, Laurent ;
Cazzagon, Nora ;
Friedrich-Rust, Mireen ;
Petta, Salvatore ;
Thiele, Maja .
JOURNAL OF HEPATOLOGY, 2021, 75 (03) :659-689
[5]  
Burt AD., 2007, MacSween's Pathology of the Liver, V5th
[6]   Noninvasive, Quantitative Assessment of Liver Fat by MRI-PDFF as an Endpoint in NASH Trials [J].
Caussy, Cyrielle ;
Reeder, Scott B. ;
Sirlin, Claude B. ;
Loomba, Rohit .
HEPATOLOGY, 2018, 68 (02) :763-772
[7]   The diagnosis and management of nonalcoholic fatty liver disease: Practice guidance from the American Association for the Study of Liver Diseases [J].
Chalasani, Naga ;
Younossi, Zobair ;
Lavine, Joel E. ;
Charlton, Michael ;
Cusi, Kenneth ;
Rinella, Mary ;
Harrison, Stephen A. ;
Brunt, Elizabeth M. ;
Sanyal, Arun J. .
HEPATOLOGY, 2018, 67 (01) :328-357
[8]   Application of Artificial Intelligence for Diagnosis and Risk Stratification in NAFLD and NASH: The State of the Art [J].
Dinani, Amreen M. ;
Kowdley, Kris V. ;
Noureddin, Mazen .
HEPATOLOGY, 2021, 74 (04) :2233-2240
[9]  
EASL, 2016, OBESITY FACTS, V9, P65, DOI [10.1159/000443344, 10.1016/j.jhep.2015.11.004, 10.1007/s00125-016-3902-y]
[10]   Long-term follow-up of patients with NAFLD and elevated liver enzymes [J].
Ekstedt, Mattias ;
Franzen, Lennart E. ;
Mathiesen, Ulrik L. ;
Thorelius, Lars ;
Holmqvist, Marika ;
Bodemar, Goran ;
Kechagias, Stergios .
HEPATOLOGY, 2006, 44 (04) :865-873